Drug profile · INN
balsalazide disodium
BALSALAZIDE DISODIUM
balsalazide disodium (BALSALAZIDE DISODIUM) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — balsalazide disodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
balsalazide disodium (BALSALAZIDE DISODIUM) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Polyunsaturated fatty acid 5-lipoxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Congress & event coverage
- PresentationPharma Manufacturing World
Related & competitor drugs
Frequently asked questions
What is balsalazide disodium?
balsalazide disodium (BALSALAZIDE DISODIUM) is a cyclooxygenase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for balsalazide disodium?
BALSALAZIDE DISODIUM is a marketed brand name for balsalazide disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of balsalazide disodium?
balsalazide disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.